33,273 followers
New Research: Interleukin-10 Is a Promising Marker for Immune-Related Adverse Events in Patients With Non-Small Cell Lung Cancer Receiving Immunotherapy: Background Immune checkpoint inhibitors (ICIs) brought about a major paradigm shift in… https://t.co/